|Articles|February 2, 2003
- Pharmaceutical Technology-02-02-2003
- Volume 27
- Issue 2
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Author(s)Michael Mitchell
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Advertisement
Articles in this issue
over 23 years ago
A Stress Testing Benchmarking Studyover 23 years ago
Cleanroom Pressurization Methodologyover 23 years ago
Manufacturing Capability Key to Global Health Advancesover 23 years ago
February 2003over 23 years ago
Outsourcing OutlookAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
4
The Implications of the FDA’s New Finalized Guidance Documents
5